Hepatitis C virus infection and the risk of coronary disease.

BACKGROUND The association between hepatitis C virus (HCV) infection and coronary artery disease (CAD) is controversial. We conducted this study to determine and quantify this association. METHODS We used an established, national, observational cohort of all HCV-infected veterans receiving care at all Veterans Affairs facilities, the Electronically Retrieved Cohort of HCV Infected Veterans, to identify HCV-infected subjects and HCV-uninfected control subjects. We used the Cox proportional-hazards model to determine the risk of CAD among HCV-infected subjects and control subjects. RESULTS We identified 82,083 HCV-infected and 89,582 HCV-uninfected subjects. HCV-infected subjects were less likely to have hypertension, hyperlipidemia, and diabetes but were more likely to abuse alcohol and drugs and to have renal failure and anemia. HCV-infected subjects had lower mean (+/- standard deviation) total plasma cholesterol (175 +/- 40.8 mg/dL vs. 198 +/- 41.0 mg/dL), low-density lipoprotein cholesterol (102 +/- 36.8 mg/dL vs. 119 +/- 38.2 mg/dL), and triglyceride (144 +/- 119 mg/dL vs. 179 +/- 151 mg/dL) levels, compared with HCV-uninfected subjects (P < .001 for all comparisons). In multivariable analysis, HCV infection was associated with a higher risk of CAD (hazard ratio, 1.25; 95% confidence interval, 1.20-1.30). Traditional risk factors (age, hypertension, chronic obstructive pulmonary disease, diabetes, and hyperlipidemia) were associated with a higher risk of CAD in both groups, whereas minority race and female sex were associated with a lower risk of CAD. CONCLUSIONS HCV-infected persons are younger and have lower lipid levels and a lower prevalence of hypertension. Despite a favorable risk profile, HCV infection is associated with a higher risk of CAD after adjustment for traditional risk factors.

[1]  Joseph Erdos,et al.  Comparison of Two VA Laboratory Data Repositories Indicates That Missing Data Vary Despite Originating From the Same Source , 2009, Medical care.

[2]  B. Afşar,et al.  Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients , 2008, European Journal of Clinical Nutrition.

[3]  O. Ozdemir,et al.  Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[4]  C. Kwoh,et al.  Co‐morbid medical and psychiatric illness and substance abuse in HCV‐infected and uninfected veterans , 2007 .

[5]  M. Abdel-hamid,et al.  Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt , 2006, Gut.

[6]  C. Kwoh,et al.  Rate and predictors of treatment prescription for hepatitis C , 2006, Gut.

[7]  P. Shapshak,et al.  Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. , 2006, Drug and alcohol dependence.

[8]  S. Crystal,et al.  Increased COPD among HIV-positive compared to HIV-negative veterans. , 2006, Chest.

[9]  K. Nelson,et al.  No association between hepatitis C virus seropositivity and acute myocardial infarction. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Kwoh,et al.  Rates and predictors of hepatitis C virus treatment in HCV–HIV‐coinfected subjects , 2006, Alimentary pharmacology & therapeutics.

[11]  L. Rabeneck,et al.  Medical Disease and Alcohol Use Among Veterans With Human Immunodeficiency Infection: A Comparison of Disease Measurement Strategies , 2006, Medical care.

[12]  Melissa Skanderson,et al.  Development and Verification of a “Virtual” Cohort Using the National VA Health Information System , 2006, Medical care.

[13]  J. Hayashi,et al.  Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. , 2006, Fukuoka igaku zasshi = Hukuoka acta medica.

[14]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[15]  S. Riordan,et al.  Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury , 2006, Inflammation Research.

[16]  A. Lekkou,et al.  Serum lipid pattern in chronic hepatitis C: histological and virological correlations , 2006, Journal of viral hepatitis.

[17]  A. Sanyal Review article: non‐alcoholic fatty liver disease and hepatitis C – risk factors and clinical implications , 2005, Alimentary pharmacology & therapeutics.

[18]  A. Justice,et al.  Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans , 2005, AIDS.

[19]  G. Zoppini,et al.  Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[20]  Reiko Ohmori,et al.  Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease. , 2005, Atherosclerosis.

[21]  R. Manfro,et al.  Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  G. Hansson Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[23]  Xiao-hua Wang,et al.  Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. , 2005, World journal of gastroenterology.

[24]  H. El‐Serag,et al.  Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. , 2005, Journal of hepatology.

[25]  A. Butt,et al.  Reasons for non‐treatment of hepatitis C in veterans in care , 2005, Journal of viral hepatitis.

[26]  Peter J. Richardson,et al.  The Effect of HIV Coinfection on the Risk of Cirrhosis and Hepatocellular Carcinoma in U.S. Veterans with Hepatitis C , 2005, The American Journal of Gastroenterology.

[27]  K. Jármay,et al.  Changes in lipid metabolism in chronic hepatitis C. , 2002, World journal of gastroenterology.

[28]  P. Kearney,et al.  Acute coronary syndrome and chronic infection in the Cork coronary care case–control study , 2004, Heart.

[29]  Peter J. Richardson,et al.  Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. , 2004, Archives of internal medicine.

[30]  U. John,et al.  Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. , 2004, Atherosclerosis.

[31]  F. Bianchi,et al.  Evidence for association between hepatitis C virus seropositivity and coronary artery disease , 2004, Heart.

[32]  R. Stravitz,et al.  Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome , 2003, American Journal of Gastroenterology.

[33]  Jianglin Fan,et al.  Inflammatory reactions in the pathogenesis of atherosclerosis. , 2003, Journal of atherosclerosis and thrombosis.

[34]  T. Yoshikawa,et al.  Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. , 2003, JAMA.

[35]  T. Louis,et al.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. , 2003, The New England journal of medicine.

[36]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[37]  R. Nagai,et al.  Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening , 2002, The Lancet.

[38]  I. Fong Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[39]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[40]  R. Hariman,et al.  Cocaine‐Related Sudden Cardiac Death: A Hypothesis Correlating Basic Science and Clinical Observations , 1994, Journal of clinical pharmacology.

[41]  R. Virmani,et al.  Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. , 1991, Journal of the American College of Cardiology.

[42]  A. Gradman Cardiac effects of cocaine: a review. , 1988, The Yale journal of biology and medicine.